CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
39 hedge funds and large institutions have $41.7M invested in Cyteir Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
70% less capital invested
Capital invested by funds: $137M → $41.7M (-$95.1M)
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.99M | |
| 2 | +$1.36M | |
| 3 | +$1.05M | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
+$856K |
| 5 |
VAM
Vazirani Asset Management
New York
|
+$406K |
Top Sellers
| 1 | -$3.7M | |
| 2 | -$3.21M | |
| 3 | -$722K | |
| 4 |
Morgan Stanley
New York
|
-$310K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$301K |